One of the biggest recent milestones for Hikma’s global operations must have been the acquisition of Ribosepharm and Thymoorgan in 2007. How successfully have the two…
In Conversation
You have a wide professional experience that goes from financial adviser to biotechnology entrepreneur, passing through software business and politics. How will all of those different…
Your interest in bioinformatics has run though your academic career and now into your business career as CEO and founder of Biomax Informatics; what was your…
Given the heated debate over NHS reform and the new revised bill proposed by the government, what are you current priorities as President of the ABPI…
Could you give us a brief introduction to IMS’ business model? What would you say are the main challenges encountered today in the German market for…
BioSino has experienced many changes since it was first established and has taken on many different forms and functions. Can you provide a brief history of…
¿Cual fue la visión detrás de la creación de IBC y Dromex? Nuestro negocio original consistía en representar comercialmente a los fabricantes de APIs europeos. Esto…
¿Cuál es la historia de Laboratorios Poen y como ha crecido en los últimos años? Poen se inició siendo un pequeño laboratorio de capitales nacionales dedicado…
The DKFZ – German Cancer Research Center – is Germany’s largest cancer research institute with an international recognition recently coroneted with the Nobel Prize to Mr…
2007 was a turning point for the German Pharmaceutical Industry as the Healthcare Reform from 2007 took place and the Special SHI enhancement Act entered into…
You were General Manager of Pfizer Peru and Pfizer Venezuela before taking on the challenge of the Argentinean market. How difficult was the experience of adjusting…
What role does the German Pharmaceutical Industry Association (BPI) play for the German pharmaceutical industry? BPI is the oldest industry association of the German pharmaceutical industry,…
